GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $51,593,000 | +6.0% | 1,185,225 | +6.0% | 0.00% | +100.0% |
| Q1 2022 | $48,684,000 | -1.9% | 1,117,631 | -0.7% | 0.00% | 0.0% |
| Q4 2021 | $49,646,000 | +30.0% | 1,125,751 | +12.6% | 0.00% | 0.0% |
| Q3 2021 | $38,201,000 | +4.2% | 999,770 | +8.6% | 0.00% | 0.0% |
| Q2 2021 | $36,669,000 | +40.5% | 920,878 | +25.9% | 0.00% | 0.0% |
| Q1 2021 | $26,106,000 | +17304.0% | 731,455 | +17871.9% | 0.00% | – |
| Q4 2020 | $150,000 | -99.3% | 4,070 | -99.3% | 0.00% | -100.0% |
| Q3 2020 | $22,181,000 | -52.7% | 589,281 | -48.7% | 0.00% | -50.0% |
| Q2 2020 | $46,901,000 | -11.5% | 1,149,792 | -17.8% | 0.00% | -33.3% |
| Q1 2020 | $52,998,000 | -36.2% | 1,398,740 | -20.9% | 0.00% | 0.0% |
| Q4 2019 | $83,047,000 | +28.5% | 1,767,340 | +16.7% | 0.00% | 0.0% |
| Q3 2019 | $64,626,000 | +5.7% | 1,514,210 | -0.8% | 0.00% | 0.0% |
| Q2 2019 | $61,115,000 | +12.9% | 1,527,105 | +17.9% | 0.00% | +50.0% |
| Q1 2019 | $54,111,000 | +19.9% | 1,294,839 | +9.6% | 0.00% | 0.0% |
| Q4 2018 | $45,147,000 | -21.0% | 1,181,541 | -16.9% | 0.00% | 0.0% |
| Q3 2018 | $57,125,000 | -10.1% | 1,422,077 | -9.8% | 0.00% | -33.3% |
| Q2 2018 | $63,573,000 | +27.5% | 1,577,096 | +23.6% | 0.00% | +50.0% |
| Q1 2018 | $49,851,000 | +71.1% | 1,275,942 | +55.3% | 0.00% | +100.0% |
| Q4 2017 | $29,135,000 | -39.7% | 821,388 | -31.0% | 0.00% | -50.0% |
| Q3 2017 | $48,320,000 | +13.6% | 1,190,136 | +20.7% | 0.00% | 0.0% |
| Q2 2017 | $42,518,000 | +30.5% | 986,048 | +27.6% | 0.00% | 0.0% |
| Q1 2017 | $32,586,000 | +77485.7% | 772,912 | +70164.7% | 0.00% | – |
| Q4 2016 | $42,000 | +90.9% | 1,100 | +120.0% | 0.00% | – |
| Q3 2016 | $22,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2016 | $22,000 | -8.3% | 500 | -16.7% | 0.00% | – |
| Q1 2016 | $24,000 | -25.0% | 600 | -25.0% | 0.00% | – |
| Q4 2015 | $32,000 | -74.4% | 800 | -68.0% | 0.00% | – |
| Q3 2013 | $125,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q2 2013 | $125,000 | – | 2,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |